Studies & Guidelines Archives - CME Travel Academy

Top 5 Chronic Disease Studies of 2025 and Outlook for 2026

The chronic disease landscape in 2025 has been shaped by groundbreaking cardiovascular trials, innovative AI-driven prediction models, comprehensive global burden assessments, and novel therapeutic approaches targeting inflammation and metabolism. Here are the five most impactful studies advancing our understanding and management of chronic disease. 1. Cardiovascular-Kidney-Metabolic Health Framework: A Paradigm Shift in Heart Failure Prevention The Lancet […]

Top 5 Chronic Disease Studies of 2025 and Outlook for 2026 Read More »

What’s New in the ADA 2026 Diabetes Guidelines (compared to 2025)

The American Diabetes Association (ADA) Standards of Care in Diabetes—2026 brings important updates that reflect the latest evidence and real-world clinical experience in diabetes care. These guidelines — published as an annual supplement to Diabetes Care — guide clinicians on diagnosis, management, prevention, and complication care across the lifespan. Join us for an in depth

What’s New in the ADA 2026 Diabetes Guidelines (compared to 2025) Read More »

Latest Kidney Disease KDIGO Guideline Highlights: What Clinicians Need to Know

The 2024 KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) introduces the most significant updates since 2012. The new recommendations reflect major advances in risk stratification, GFR estimation, and disease-modifying therapies that meaningfully slow CKD progression and reduce cardiovascular risk. This summary highlights the essential changes relevant to primary

Latest Kidney Disease KDIGO Guideline Highlights: What Clinicians Need to Know Read More »

Comprehensive Depression Management in Primary Care

Depression is one of the most common mental health conditions encountered in primary care, internal medicine, and family practice settings, affecting millions of adults annually. Early identification and evidence-based management are essential to improving patient outcomes, quality of life, and functional recovery. However, many clinicians face challenges in integrating mental health care into busy practices.

Comprehensive Depression Management in Primary Care Read More »

CME Travel Academy - travel and learn about heart failure

The New Era in Heart Failure Management: What Every Clinician Should Know About the Latest Guidelines

The Changing Landscape of Heart Failure Care Heart failure (HF) continues to be a major public health challenge, affecting more than 6 million adults in the United States alone. Despite advances in therapy, hospitalizations and mortality remain high—often because patients do not receive the full spectrum of evidence-based care. Over the past few years, major

The New Era in Heart Failure Management: What Every Clinician Should Know About the Latest Guidelines Read More »

GINA 2025: Personalized Asthma Management

The 2025 GINA guidelines emphasize a personalized approach to asthma care, integrating biological, lifestyle, and environmental factors into treatment decisions. The “Assess-Adjust-Review” cycle encourages clinicians to: This approach aims to enhance patient outcomes by aligning treatment with individual needs and circumstances. Treatment Strategies: Tracks 1 and 2 GINA maintains a two-track treatment strategy for adolescents

GINA 2025: Personalized Asthma Management Read More »

An In-Depth Look at the 2025 COPD Guidelines

Chronic Obstructive Pulmonary Disease (COPD) remains a leading cause of morbidity and mortality worldwide. The 2025 COPD Guidelines bring forward significant updates designed to improve early recognition, personalize treatment, and prevent exacerbations. These changes reflect both evolving evidence and the growing recognition that COPD is not a “one-size-fits-all” condition, but a complex disease with heterogeneous

An In-Depth Look at the 2025 COPD Guidelines Read More »

SGLT2 Inhibitors in Heart Failure: Underused Even Among Cardiologists?

A Missed Opportunity: SGLT2 inhibitors in Heart Failure Care Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have transformed heart failure management, reducing both hospitalizations and cardiovascular deaths across the ejection fraction spectrum. Guidelines now recommend SGLT2i as foundational therapy for patients with heart failure—yet real-world prescribing still lags far behind. A new retrospective cohort study of over

SGLT2 Inhibitors in Heart Failure: Underused Even Among Cardiologists? Read More »

2025 AHA/ACC Hypertension Guidelines | CME Travel Academy

New Horizons in Hypertension Management: 2025 AHA/ACC Guidelines Hypertension remains a leading driver of cardiovascular disease, stroke, and kidney disease worldwide. The 2025 AHA/ACC guidelines provide updated recommendations to help clinicians identify, manage, and treat high blood pressure more effectively. At CME Travel Academy, we’re excited to dive into these updates at our upcoming conferences

2025 AHA/ACC Hypertension Guidelines | CME Travel Academy Read More »